| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/13/2002 | EP1179020A1 Low-dose il-1beta-induced photoreceptor cell rescue without retinal dysplasia |
| 02/13/2002 | EP1179005A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| 02/13/2002 | EP1178993A1 Thiazoloderiatives and pharmaceutical compositions containing them |
| 02/13/2002 | EP1178990A1 Imidazodiazepine derivative |
| 02/13/2002 | EP1178984A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 02/13/2002 | EP1178983A1 Indole-type derivatives as inhibitors of p38 kinase |
| 02/13/2002 | EP1178982A1 Heterocyclic substituted aminoazacycles useful as central nervous system agents |
| 02/13/2002 | EP1178981A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 02/13/2002 | EP1178977A1 Ion channel modulating agents |
| 02/13/2002 | EP1178973A2 Novel compounds, their use and preparation |
| 02/13/2002 | EP1178969A1 Gastrin and cholecystokinin receptor ligands |
| 02/13/2002 | EP1178963A1 Ion channel modulating agents |
| 02/13/2002 | EP1178962A1 Process for the preparation of paroxetine acetate and analogues thereof |
| 02/13/2002 | EP1178959A1 Alpha-amino-beta-sulfonyl hydroxamic acid compounds |
| 02/13/2002 | EP1178958A2 N-cyanomethyl amides as protease inhibitors |
| 02/13/2002 | EP1178953A1 Aromatic amides |
| 02/13/2002 | EP1178825A2 Adjuvant combination formulations |
| 02/13/2002 | EP1178809A1 Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate |
| 02/13/2002 | EP1178805A1 Novel synthesis and crystallization of piperazine ring-containing compounds |
| 02/13/2002 | EP1178803A2 Opioid antagonists containing compositions for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 02/13/2002 | EP1178802A1 Cyclic amidines useful as nmda nr2b antagonists |
| 02/13/2002 | EP1178800A1 Methods for treating neurodegenerative disorders using aspartyl protease inhibitors |
| 02/13/2002 | EP1178798A1 Parenteral formulation of 5-(2-chloroethyl)-4-methylthiazole edisylate(clomethiazole edisylate) |
| 02/13/2002 | EP1178796A1 Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
| 02/13/2002 | EP1178794A1 Use of succinic acid derivatives to obtain a medicine for treating inflammation |
| 02/13/2002 | EP1178792A1 Aryl amidines, compositions containing such compounds and methods of use |
| 02/13/2002 | EP1178789A1 Method of treating eating disorders |
| 02/13/2002 | EP1178785A1 Compositions and methods for identifying antigens which elicit an immune response |
| 02/13/2002 | EP1178784A1 New pharmaceutical combinations for nos inhibitors |
| 02/13/2002 | EP1178780A1 Multiparticulate controlled release selective serotonin reuptake inhibitor formulations |
| 02/13/2002 | EP1178740A1 New composition |
| 02/13/2002 | EP0946561B1 Triazolo(4,5-d)pyrimidinyl derivatives and their use as medicaments |
| 02/13/2002 | EP0861250B1 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase |
| 02/13/2002 | EP0861081B1 Use of epinastine in the treatment of pain |
| 02/13/2002 | EP0769957B1 Methods for treating motor deficits |
| 02/13/2002 | EP0737199B1 Method for preparing concentrated biologically active silicon compounds |
| 02/13/2002 | CN1335881A UME extract having medicinal effects and compositions containing the same |
| 02/13/2002 | CN1335850A Quinoline derivatives |
| 02/13/2002 | CN1335849A Pyrrolopyrimidines as protein kinase inhibitors |
| 02/13/2002 | CN1335846A Pyrano, piperidino and thiopyrano compounds and methods of use |
| 02/13/2002 | CN1335845A 3,4-dihydro-2H-benzo[1,4] oxazinyl-methyl [3-(1H-indol-3-yl)-alkyl]-amines |
| 02/13/2002 | CN1335844A New 1,4-disubstituted cyclohexane derivatives for the treatment of depression |
| 02/13/2002 | CN1335841A N-(iminomethyl) amine derivatives, their preparation, their use as medicines and compositions containing them |
| 02/13/2002 | CN1335838A Pyrimidine compounds |
| 02/13/2002 | CN1335835A Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5HT1A receptor activity |
| 02/13/2002 | CN1335769A Controlled release formulation of divalproex sodium |
| 02/13/2002 | CN1335768A Multiparticulate modified release composition |
| 02/13/2002 | CN1335767A Sustained release matrix systems for highly soluble drugs |
| 02/13/2002 | CN1335316A New N-triazolyl methyl piperazine derivate using as neurokinin receptor antagonistic agent |
| 02/13/2002 | CN1335304A Novel carbamic acid ester compound containing amino thionic group and its producing process |
| 02/13/2002 | CN1335154A Headache treating capsule |
| 02/13/2002 | CN1335102A Production process of sobering-up beverage |
| 02/12/2002 | US6346622 Enantiomorphs and isomers |
| 02/12/2002 | US6346620 Methods for preparation of 2-(4-(4-(4,5-dichloro-2-methylimidazol-1-yl)butyl)-1-piperazinyl)-5-fluoropyrimidine and salts thereof |
| 02/12/2002 | US6346611 High affinity TGfβ nucleic acid ligands and inhibitors |
| 02/12/2002 | US6346607 A protein that induces apoptosis or binds cytochrome c; diagnosis and therapy for multiple sclerosis, parkinson's and alzheimer's diseases, cardiovascular diseases, strokes, toxin induced liver disease, cancer, lupus and herpes virus |
| 02/12/2002 | US6346548 Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
| 02/12/2002 | US6346547 N-substituted amino acids, antioxidant pharmaceutical compositions containing n-substituted amino acids and methods for preventing cardiovascular diseases and/or preventing and/or treating antioxidant responsive diseases therewith |
| 02/12/2002 | US6346528 Side effect reduction compared to olanzapine; capsules or tablets; psychological, gastrointestinal and bipolar disorders; anxiolytic agents, antidepressants |
| 02/12/2002 | US6346409 Tryptophenyl tRNA synthetase from Streptococcus pneumoniae |
| 02/12/2002 | US6346283 Nervous system disorders |
| 02/12/2002 | US6346282 Synergistic compositions for treating nervous system disorders |
| 02/12/2002 | US6346278 Lipid extract of perna or mytilus |
| 02/12/2002 | US6346246 Antibodies that bind human haemopoietic maturation factor |
| 02/12/2002 | CA2227194C Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-n-[[2-methoxy-5-(1-methylethyl)phenyl]methyl] |
| 02/12/2002 | CA2215303C Sertoli cells as transplantation facilitator for cell transplantation |
| 02/12/2002 | CA2094702C Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents |
| 02/12/2002 | CA2057504C Process for preparing new n-acyl-2,3-benzodiazepine derivatives, their acid addition salts and pharmaceutical compositions containing the same |
| 02/12/2002 | CA2053705C Piperazine derivatives |
| 02/12/2002 | CA2048139C N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present |
| 02/12/2002 | CA2043131C Brain resuscitation device and method for performing the same |
| 02/07/2002 | WO2002010743A1 Improved anti-viral and anti-tumor chemotherapy by administration of erythropoeitin |
| 02/07/2002 | WO2002010403A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
| 02/07/2002 | WO2002010388A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
| 02/07/2002 | WO2002010387A2 G-protein coupled receptors |
| 02/07/2002 | WO2002010371A1 Novel physiologically active peptide and use thereof |
| 02/07/2002 | WO2002010363A2 Protein phosphatases |
| 02/07/2002 | WO2002010357A2 Gsk3 polypeptides |
| 02/07/2002 | WO2002010347A2 Directed differentiation of embryonic cells |
| 02/07/2002 | WO2002010216A2 Proteins and nucleic acids encoding same |
| 02/07/2002 | WO2002010214A2 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 02/07/2002 | WO2002010199A2 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | WO2002010175A1 PYRROLO[2,1-b][1,3]BENZOTHIAZEPINES AND THEIR USE FOR THE PREPARATION OF MEDICAMENTS WITH ANTIPSYCHOTIC ACTIVITY |
| 02/07/2002 | WO2002010174A1 Process for the preparation of 9-amino substituted 9,10-dihydropyrrolo [2,1-b][1,3]benzotiazepines |
| 02/07/2002 | WO2002010170A1 Imidazo-pyrazine derivatives as ligands for gaba receptors |
| 02/07/2002 | WO2002010169A1 Piperazine derivatives |
| 02/07/2002 | WO2002010167A1 Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient |
| 02/07/2002 | WO2002010166A1 Fused heterocyclic derivatives as phosphodiesterase inhibitors |
| 02/07/2002 | WO2002010164A2 Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers |
| 02/07/2002 | WO2002010161A1 Process for preparing arylacetylaminothiazoles |
| 02/07/2002 | WO2002010158A2 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 02/07/2002 | WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | WO2002010143A1 Non-steroidal inflammation inhibitors |
| 02/07/2002 | WO2002010141A1 Imidazole derivatives |
| 02/07/2002 | WO2002010140A2 Imidazolyl derivatives |
| 02/07/2002 | WO2002010139A1 Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase |
| 02/07/2002 | WO2002010137A2 Indazole derivatives as jnk inhibitors |
| 02/07/2002 | WO2002010136A1 3-substituted isoquinolin-1-yl derivatives |
| 02/07/2002 | WO2002010135A1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 02/07/2002 | WO2002009768A2 Therapeutic polyesters and polyamides |